Assessing the Efficacy of DuoTrav as a Replacement Therapy in Glaucoma Patients in Russia

NCT01696383 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Management decision

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: Travoprost 0.004%/Timolol 0.5% Fixed Combination (DuoTrav)

Sponsor

Alcon Research